| Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center |
2006-002450-30: An Open label Study to Compare Systemic Side Effects of High Dose Fluticasone/Salmeterol with that of High Dose Ciclesonide /Salmeterol in Symptomatic Asthmatics |
|
|
| Ongoing | 4 | 20 | Europe | Alvesco 160 inhaler, Flixotide Accuhaler, Alvesco 160 inhaler, Flixotide Accuhaler | Hull and East Yorkshire Hospitals Trust | Chronic asthma | | | | |
NCT03141424: Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma |
|
|
| Recruiting | 4 | 110 | Europe | Tapering of inhaled corticosteroid (ICS) treatment, budesonide, fluticasone proprionate, mometasone furoate, beclometasone dipropionate, ciclesonide | Hvidovre University Hospital | Asthma | 06/24 | 06/24 | | |
| Recruiting | 2/3 | 5000 | Europe | Niclosamide, Placebo, Ciclesonide, Sotrovimab | Cambridge University Hospitals NHS Foundation Trust, Life Arc, Kidney Research UK (KRUK), UNION therapeutics, Addenbrookes Charitable Trust, GlaxoSmithKline, National Institute for Health Research, United Kingdom | Covid19 | 07/24 | 12/24 | | |
2004-001838-16: Efficacy and safety of a fixed combination of ciclesonide and formoterol once or twice daily in the treatment of persistent asthma A randomized, double-blind, placebo-controlled, parallel-group, multi-center study |
|
|
| Ongoing | 2 | 100 | Europe | Ciclesonide/Formoterol Fixed Combination, Ciclesonide-Mono DPI, BY9010, | ALTANA Pharma AG | asthma bronchiale | | | | |
2020-001928-34: Treatment with inhalation of Ciclesonide for patients with coronavirus disease: A randomised open study. Behandling med inhalation av Ciklesonid till patienter med coronavirussjukdom: En randomiserad oblindad behandlingsstudie. |
|
|
| Ongoing | 2 | 446 | Europe | Pressurised inhalation, solution, Alvesco | Capio S:t Görans Sjukhus, Axel och Margaret Ax:son Johnsons stiftelse för allmännyttiga ändamål | Covid-19 pneumonia, Coronavirus disease, Diseases [C] - Virus Diseases [C02] | | | | |
HALT, NCT04381364: Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study ( COVID-19) |
|
|
| Active, not recruiting | 2 | 98 | Europe | Ciclesonide Inhalation Aerosol, Alvesco | Ola Blennow, MD, PhD, Karolinska University Hospital, Danderyd Hospital, Centrallasarettet Västerås | Covid-19, Pneumonia, Viral, Sars-CoV2 | 08/21 | 01/22 | | |
2020-002208-37: CIMMCov: A randomized clinical study for prevention of severe disease in mild-to-moderate COVID-19 patients, using the inhaled medication Ciclesonide. CIMMCov: Et randomiseret klinisk studie for forebyggelse af forværring af mild til moderat COVID-19-sygdom ved brug af inhalationsmedicinen Ciclesonid. |
|
|
| Not yet recruiting | 2 | 138 | Europe | Alvesco, 081801, Inhalation vapour, liquid, Alvesco | Respiratory Research Unit 237, Hvidovre Hospital, Covis Pharma | COVID-19 pneumonia, Coronavirus (COVID-19) infection in the lungs, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
| Not yet recruiting | 1 | 30 | NA | Alvesco Inhalant Product, ciclesonide | Children's Mercy Hospital Kansas City, University of Pittsburgh, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Bronchopulmonary Dysplasia | 08/26 | 08/26 | | |